Client news

A&O Shearman advises Halma on its acquisition of Dreampath Diagnostics

A&O Shearman advises Halma on its acquisition of Dreampath Diagnostics
Published Date
Jul 10 2026
Related people
Image of Anne-Caroline Payelle
Anne-Caroline PayellePartner, Paris
Image of Charles del Valle
Charles del VallePartner, Paris
Image of Florence Ninane
Florence NinanePartner, Paris
Image of Olivier Picquerey
Olivier PicquereyPartner, Paris
Image of Luc Lamblin
Luc LamblinCounsel, Paris
Image of Marianne Delassaussé
Marianne DelassausséPeerpoint Consultant, Paris
Image of Clémence d'Almeida
Clémence d'AlmeidaSenior Associate, Paris
Image of Antoine Messent
Antoine MessentAssociate, Paris
Image of Thibault Faivre-Pierret
Thibault Faivre-PierretSenior Associate, Paris
Image of Yasmine Benhmida
Yasmine BenhmidaAssociate, Paris
Image of Ahmed Ben Hafsia
Ahmed Ben HafsiaAssociate, Paris
Image of Naomi-Lan Leroy
Naomi-Lan LeroyAssociate, Paris
Image of Loma Pavion
Loma PavionAssociate, Paris
A&O Shearman advised Halma plc, the global group of life-saving technology companies, on its acquisition of Dreampath Diagnostics, a French provider of automation solutions for anatomic pathology laboratories.

The deal helps Halma grow in a fast-expanding segment fueled by rising diagnostic demand and tighter regulatory requirements around sample traceability. By bringing Dreampath Diagnostics’ capabilities into the fold, the acquisition strengthens Halma’s healthcare sector and broadens its technology portfolio with solutions that improve patient safety, diagnostic accuracy, and lab efficiency.

“We are thrilled to have advised Halma on this strategic acquisition, which speaks to the strong momentum we’re seeing across the life sciences and diagnostics space. It also showcases A&O Shearman’s ability to deliver on complex cross-border deals by drawing on our deep sector knowledge and global platform,” said Anne-Caroline Payelle, partner at Paris office.

Halma is a London Stock Exchange-listed global technology group with operations in more than 20 countries. The company focuses on growing a safer, cleaner, healthier future for everyone, every day. It buys and grows companies that provide innovative solutions to many of the key challenges facing the world today.

Our multidisciplinary team advised Halma on all legal aspects of the transaction. The transaction was led by Anne-Caroline Payelle, Antoine Messent and Yasmine Benhmida, working closely with Olivier Picquerey and Naomi-Lan Leroy on employment matters, Charles del Valle and Thibault Faivre-Pierret on tax matters, Florence Ninane, Clémence d'Almeida and Loma Pavion on antitrust matters, Marianne Delassaussé on intellectual property matters, Laurie-Anne Ancenys and Juliette Mazilier on IT and data matters and Luc Lamblin and Ahmed Ben Hafsia on foreign investment matters. The transaction also drew on the expertise of colleagues across our U.S. offices, as well as our teams in Madrid and London.

 

Related capabilities